Related Experiment Video
Updated: May 30, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Antiviral therapy for hepatitis B infection during pregnancy and breastfeeding
Michelle Giles1, Kumar Visvanathan, Joe Sasadeusz
1Infectious Diseases Unit, Alfred Hospital, Melbourne, Australia. m.giles@alfred.org.au
Abstract:
It is estimated there are 350-400 million people worldwide chronically infected with HBV. Many of these are women and of reproductive age. As such, they may face therapeutic decisions regarding antiviral therapy and the implication this may have on future or current pregnancies. This article reviews the data of all antivirals licensed for use against hepatitis B infection regarding teratogenicity, carcinogenicity, clinical experience during pregnancy, placental transfer and excretion in breast milk.
More Related Videos
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
09:35Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Published on: February 1, 2017
Related Concept Videos
Antiviral Nucleoside Inhibitors
Hepatitis
Inhibitors of Viral Protein Synthesis
Viral Hepatitis I: Introduction
Pharmacokinetics in Pediatric Patients: Drug Excretion
Retrovirus Life Cycles